Jing Liu

12PUBLICATIONS
29CO-AUTHORS
Biomolecular modelling and designPsychosocial aspects of childbirth and perinatal mental healthPharmacogenomicsMolecular medicineAir pollution modelling and control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 05, 2026
Physiologically Based Pharmacokinetic Modeling to Assess Transporter-Mediated Drug-Drug Interactions in Support of Labeling Recommendations for Zavegepant Nasal Spray.

|Jan 08, 2026
A phase 1 study of the breast milk and plasma pharmacokinetics of zavegepant 10 mg intranasal dose in healthy lactating women.

Abhijeet Jakate, Yan Weng, Ani Shkrodova

|Oct 17, 2025
Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With Migraine.

Craig M Comisar, Jim H Hughes, Gary Mo

|Jul 04, 2025
Population Pharmacokinetic Modeling of the Oral Calcitonin Gene-Related Peptide Receptor Antagonist Rimegepant in Adults.

Craig M Comisar, Jim H Hughes, Jose Francis

|Nov 27, 2024
Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.

Rajinder Bhardwaj, Jo Ann Malatesta, Jennifer Madonia

|Nov 04, 2024
Population pharmacokinetic modeling of zavegepant, a calcitonin gene-related peptide receptor antagonist, in healthy adults and patients with migraine.

Craig M Comisar, Jose Francis, Jim H Hughes

Pageof 2

Frequent Collaborators

7 joint publications

Richard Bertz

6 joint publications

Rajinder Bhardwaj

4 joint publications

Beth Morris

4 joint publications

Kyle T Matschke